These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 621391)
81. Generation and secretion of eosinophilotactic activity from human polymorphonuclear neutrophils by various mechanisms of cell activation. König W; Frickhofen N; Tesch H Immunology; 1979 Apr; 36(4):733-42. PubMed ID: 437847 [TBL] [Abstract][Full Text] [Related]
82. Inhibition of neutrophil chemotaxis in association with experimental angioedema in patients with cold urticaria: a model of chemotactic deactivation in vivo. Center DM; Soter NA; Wasserman SI; Austen KF Clin Exp Immunol; 1979 Jan; 35(1):112-8. PubMed ID: 428142 [TBL] [Abstract][Full Text] [Related]
83. Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187. Borgeat P; Samuelsson B Proc Natl Acad Sci U S A; 1979 May; 76(5):2148-52. PubMed ID: 377292 [TBL] [Abstract][Full Text] [Related]
84. Platelet responses in health and disease. Barnhart MI Mol Cell Biochem; 1978 Dec; 22(2-3):113-37. PubMed ID: 370550 [TBL] [Abstract][Full Text] [Related]
85. Chemotactic factor receptors of human PMN leucocytes. I. Effects on migration of labelling plasma membrane determinants with impermeant covalent reagents and inhibition of labelling by chemotactic factors. Goetzl EJ; Hoe KY Immunology; 1979 Jun; 37(2):407-18. PubMed ID: 89083 [TBL] [Abstract][Full Text] [Related]
86. Specific inhibition of the polymorphonuclear leukocyte chemotactic response to hydroxy-fatty acid metabolites of arachidonic acid by methyl ester derivatives. Goetzl EJ; Valone FH; Reinhold VN; Gorman RR J Clin Invest; 1979 Jun; 63(6):1181-6. PubMed ID: 447841 [TBL] [Abstract][Full Text] [Related]
87. Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and random migration by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid. Goetzl EJ; Woods JM; Gorman RR J Clin Invest; 1977 Jan; 59(1):179-83. PubMed ID: 830662 [TBL] [Abstract][Full Text] [Related]
88. Generation and release of eosinophil chemotactic factor from human polymorphonuclear neutrophils by arachidonic acid. König W; Tesch H; Frickhofen N Eur J Immunol; 1978 Jun; 8(6):434-7. PubMed ID: 352712 [TBL] [Abstract][Full Text] [Related]
89. Effect of an inhibitor of TXA2 synthesis and of PGE2 on the formation of 12-L-hydroxy-5,8,10-heptadecatrienoic acid in human platelets. Vincent JE; Zijlstra FJ; van Vliet H Adv Prostaglandin Thromboxane Res; 1980; 6():463-6. PubMed ID: 7386279 [No Abstract] [Full Text] [Related]
90. Chemotactic and chemokinetic stimulation of human eosinophil and neutrophil polymorphonuclear leukocytes by 12-L-hydroxy-5,8,10-heptadecatrienoic acid (HHT). Goetzl EJ; Gorman RR J Immunol; 1978 Feb; 120(2):526-31. PubMed ID: 621391 [No Abstract] [Full Text] [Related]
91. Action and metabolism of prostaglandins in the pulmonary circulation. Kadowitz PJ; Lippton HL; McNamara DB; Spannhake EW; Hyman AL Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():333-56. PubMed ID: 6216787 [No Abstract] [Full Text] [Related]
92. Modulation of human eosinophil polymorphonuclear leukocyte migration and function. Goetzl EJ Am J Pathol; 1976 Nov; 85(2):419-36. PubMed ID: 793410 [TBL] [Abstract][Full Text] [Related]
93. [Prostoglandins and thromboxans in the regulation of bronchial function]. Szczeklik A; Nizankowska E Pol Tyg Lek; 1977 Aug; 32(35):1371-3. PubMed ID: 331287 [No Abstract] [Full Text] [Related]